MEDI7814
Product Specifications
Target
Complement System
Related Pathways
Immunology/Inflammation
Bioactivity
MEDI7814 is a humanized monoclonal antibody inhibitor targeting C5a and C5adesArg. It has binding affinities of 14 pM for recombinant human C5a and 8 pM for serum-purified human C5a. MEDI7814 shows potential for treating acute inflammatory conditions, including sepsis and renal ischemia-reperfusion injury.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15373174 1 Vial
Lentiviral human CRYZ sgRNA gene knockout kit - Lentiviral human CRYZ sgRNA gene knockout kit (100)
Ask
View Details 
MBS1369740-01 0.02 mg (E-Coli)
Recombinant Vibrio fischeri Ketol-acid reductoisomerase (ilvC)
Ask
View Details MBS1369740-02 0.02 mg (Yeast)
Recombinant Vibrio fischeri Ketol-acid reductoisomerase (ilvC)
Ask
View Details 
MBS1369740-03 0.1 mg (E-Coli)
Recombinant Vibrio fischeri Ketol-acid reductoisomerase (ilvC)
Ask
View Details MBS1369740-04 0.1 mg (Yeast)
Recombinant Vibrio fischeri Ketol-acid reductoisomerase (ilvC)
Ask
View Details MBS1369740-05 0.02 mg (Baculovirus)
Recombinant Vibrio fischeri Ketol-acid reductoisomerase (ilvC)
Ask
View Details